Birchview Capital’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Birchview Capital’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,000	Closed	-$826K	–	67
2021 Q2	$826K	Hold	30,000	–	–	0.49%	37
2021 Q1	$495K	Hold	30,000	–	–	0.29%	44
2020 Q4	$553K	Hold	30,000	–	–	0.32%	39
2020 Q3	$408K	Hold	30,000	–	–	0.27%	36
2020 Q2	$538K	Hold	30,000	–	–	0.33%	34
2020 Q1	$299K	Buy	+30,000	New	+$246K	0.27%	37

Birchview Capital's TBIO Position: Q3 2021 in Review

Birchview Capital sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 30,000 shares — an estimated $826K sold.

Birchview Capital first reported a position in TBIO in Q1 2020 and held it in 6 quarters. The position peaked at $826K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Birchview Capital reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Birchview Capital sold 30,000 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $826K.
Birchview Capital first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
Birchview Capital's Translate Bio, Inc. Common Stock position peaked at $826K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Birchview Capital's 13F filing for Q3 2021, filed 12 Nov 2021.